Medwise Overseas Profile
Key Indicators
- Authorised Capital ₹ 5.10 M
as on 09-12-2024
- Paid Up Capital ₹ 5.10 M
as on 09-12-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.20 Cr
as on 09-12-2024
- Revenue 138.98%
(FY 2022)
- Profit 66.25%
(FY 2022)
- Ebitda 202.99%
(FY 2022)
- Net Worth 139.84%
(FY 2022)
- Total Assets 177.14%
(FY 2022)
About Medwise Overseas
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.10 M and a paid-up capital of Rs 5.10 M.
The company has closed loans amounting to ₹6.20 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Niral Patel, Mauli Patel, Kalpesh Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U52100GJ2015PTC084226
- Company No.
084226
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medwise Overseas Private Limited offer?
Medwise Overseas Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Laxatives, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Nutraceuticals & Dietary Supplements, Dietary Supplements, Cleaning Liquids & Wipes, Kitchen Cleaners, Common Disease Medicines, Cough Syrup.
Who are the key members and board of directors at Medwise Overseas?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Niral Patel  | Director | 17-Aug-2015 | Current |
| Mauli Patel | Director | 17-Aug-2015 | Current |
| Kalpesh Jain | Director | 17-Aug-2015 | Current |
| Dilipkumar Patel | Director | 17-Aug-2015 | Current |
Financial Performance of Medwise Overseas.
Medwise Overseas Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 138.98% increase. The company also saw a substantial improvement in profitability, with a 66.25% increase in profit. The company's net worth Soared by an impressive increase of 139.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medwise Overseas?
In 2023, Medwise Overseas had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 15 Sep 2023 | ₹3.20 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 06 Mar 2023 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Medwise Overseas?
Medwise Overseas has a workforce of 31 employees as of Dec 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medwise Overseas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medwise Overseas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
